Le Lézard
Classified in: Health, Business
Subject: LIC

Compound Preferred Partners with MedResults Network to Provide Compounded Medications


IDAHO FALLS, Idaho, Oct. 5, 2021 /PRNewswire-PRWeb/ -- Beginning in October, Compound Preferred, a 503B outsourcing facility located in Idaho Falls, ID, is partnering with MedResults Network (MRN), a group purchasing organization with over 3,300 Members nationwide, to provide compounded medications for in-office use to all MRN Members across the United States.

"We have been searching for a 503B outsourcing facility that would meet the unique needs of MRN Members for many years now. Our priorities have been to find a team of compounding professionals that are just as dedicated to providing top-notch customer service as they are to providing high-quality products," said Jeff Routledge, President and CEO of MedResults Network. "Compound Preferred was the ideal choice. With over 45 vendors, MRN handpicks partners that fit the organization's goals of saving its Members time and money."

The partnership launches in a phased rollout to MRN Members. Phase One of the rollout will begin in October and will serve more than 300 Members in UT, ID, MT, WA, CO, OR, MI and GA. Phase Two will occur in early 2022, servicing Members in several additional states. Phase Three will occur late 2022/early 2023 and include most remaining states.

"Through this exciting and pivotal partnership, Compound Preferred and MRN will continue to provide elite customer experiences to MRN Members across the nation," said Chief Experience Officer (CXO) Cory Meyer. "By extending Compound Preferred's reach beyond the medical spa and aesthetic community, the partnership between Compound Preferred and the MedResults Network opens up opportunities for increased education on compounded products and competitive pricing for MRN's newest Members in aesthetics and the women's health market."

###

About Compound Preferred
Headquartered in Idaho Falls, ID, Compound Preferred is a full-service 503B outsourcing facility designed with the highest quality resources and FDA-regulation adherence.
Compound Preferred is dedicated to continuously meeting its customers' unique needs through easy access to safe, affordable, quality products. For more information go to https://compoundpreferred.com.
Contact Jennifer White 208-419-0613 ext. 207; [email protected]

About MedResults Network
Headquartered in Avon, CT, MedResults Network (MRN) is the largest buying network in the aesthetic medical market since 2008. With over 40 vendor contracts and nearly 3,400 Member practices and medical spas in its Network, MRN serves approximately 17% of all providers in the aesthetic medical market. MRN will be entering a second market in the fourth quarter of 2021, the women's healthcare market, a market consisting of over 43,300 OBGYN physicians.
http://www.medresultsnetwork.com
Contact Jamie Parrott Adkins (she/her) 562-673-1513; [email protected]

Media Contact

Jennifer White, Compound Preferred, 208-419-0613 x207, [email protected]

 

SOURCE Compound Preferred


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: